Cargando…

The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells

Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12–15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a stand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atif, Fahim, Patel, Neil R., Yousuf, Seema, Stein, Donald G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482510/ https://www.ncbi.nlm.nih.gov/pubmed/26110872 http://dx.doi.org/10.1371/journal.pone.0131441

Ejemplares similares

Progesterone Treatment Attenuates Glycolytic Metabolism and Induces Senescence in Glioblastoma
por: Atif, Fahim, et al.
Publicado: (2019)

Progesterone Attenuates Stress-Induced NLRP3 Inflammasome Activation and Enhances Autophagy Following Ischemic Brain Injury
por: Espinosa-Garcia, Claudia, et al.
Publicado: (2020)

Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide
por: Giannakopoulou, Maria, et al.
Publicado: (2022)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma
por: Das, Arabinda, et al.
Publicado: (2015)

Combined Effects of Doxorubicin and Temozolomide in Cultured Glioblastoma Cells
por: BALOI, CARINA, et al.
Publicado: (2022)

Temozolomide and tranilast synergistic antiproliferative effect on human glioblastoma multiforme cell line (U87MG)
por: Khazaei, Mozafar, et al.
Publicado: (2019)

Mitochondrial dysfunction contributes to Rapamycin-induced apoptosis of Human Glioblastoma Cells - A synergistic effect with Temozolomide
por: Zimmerman, Mary A, et al.
Publicado: (2020)

Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications
por: Liu, Yusi, et al.
Publicado: (2020)

Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone
por: Hua, Fang, et al.
Publicado: (2011)

Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells
por: Kaina, Bernd, et al.
Publicado: (2020)

Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy
por: BAK, DONG-HO, et al.
Publicado: (2016)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines
por: Salmaggi, Andrea, et al.
Publicado: (2021)

Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma
por: Da Ros, Martina, et al.
Publicado: (2018)

Synergistic Effects of Taurine and Temozolomide Via Cell Proliferation Inhibition and Apoptotic Induction on U-251 MG Human Glioblastoma Cells
por: Surarak, Thanakorn, et al.
Publicado: (2021)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas, Reena P, et al.
Publicado: (2012)

Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
por: Iorio, Anna Lisa, et al.
Publicado: (2017)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism
por: Zhao, Zhenran, et al.
Publicado: (2023)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Traumatic Brain Injury as a Potential Risk Factor for Diabetes Mellitus in the Veteran Population
por: Saberian, Sepehr, et al.
Publicado: (2022)

Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
por: Pedretti, M, et al.
Publicado: (2010)

N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87
por: Hanif, Farina, et al.
Publicado: (2014)

Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
por: Barazzuol, Lara, et al.
Publicado: (2013)

Inhibition of NF-κB by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ-Radiation Cytotoxicity in Glioblastoma Cells
por: Brassesco, M. S., et al.
Publicado: (2013)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury
por: Yousuf, Seema, et al.
Publicado: (2011)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
por: Cuperlovic-Culf, Miroslava, et al.
Publicado: (2014)

Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line
por: Barciszewska, Anna-Maria, et al.
Publicado: (2023)

Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts
por: Nishri, Yossi, et al.
Publicado: (2022)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jnbkp92umqfm839p3q0lhje11e